Emicizumab in the treatment of hemophilia A

Introduction: Despite substantial advances in the treatment of Hemophilia A with the use of concentrated factor VIII preparations during recent decades, bleeding episodes still occur from time to time. The development of inhibitors significantly reduces the efficacy of traditional replacement therap...

Full description

Bibliographic Details
Main Authors: Tijanić Ivan R., Golubović Ivana Z., Vučić Miodrag D., Tijanić Miloš R.
Format: Article
Language:English
Published: Medicinski fakultet i Klinika za stomatologiju, Niš 2020-01-01
Series:Acta Stomatologica Naissi
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0352-5252/2020/0352-52522081007T.pdf